4 completed, 1 unknown. 5 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Botulism: new trials by email Literature Review of Botulism trials Research Report on Botulism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Drug B11-FC (Botulism Treatment) B11-FC, Botulinum neurotoxin type A, Placebo - Botulism | Phase 1 / Phase 2 | Unknown | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 40 | 2024-08-01 | 2024-08-30 |
| Tolerability and Immunogenicity of a Single 40-ug Dose of rBV A/B for the Production of BabyBIG® rBV A/B - Botulism | Phase 2 | Completed | California Department of Public Health | 25 | 2024-07-09 | 2026-07-30 |
| Tolerability and Immunogenicity of rBV A/B for the Production of BabyBIG® rBV A/B - Botulism | Phase 2 | Completed | California Department of Public Health | 32 | 2019-03-07 | 2021-10-19 |
| Safety, Tolerability, and Immunogenicity Study of Investigational Recombinant Botulinum Vaccine A/B (rBV A/B) in Volunteers Previously Immunized With Investigational Pentavalent Botulinum Toxoid rBV A/B - Botulism | Phase 2 | Completed | California Department of Public Health | 45 | 2013-02-01 | 2017-05-16 |
| Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism 3,4-diaminopyridine - Botulism | Phase 2 / Phase 3 | Completed | Centre Hospitalier Universitaire, Amiens | 3 | 2011-09-01 | 2025-09-19 |
Bacterial Infections (5) · Bacterial Infections and Mycoses (5) · Chemically-Induced Disorders (5) · Clostridium Infections (5) · Foodborne Diseases (5) · Gram-Positive Bacterial Infections (5) · Infections (5) · Nervous System Diseases (5) · Neuromuscular Diseases (5) · Neuromuscular Junction Diseases (5) · Neurotoxicity Syndromes (5) · Poisoning (5)
Amifampridine (1) · Botulinum Toxins, Type A (1)
California Department of Public Health (3) · Centre Hospitalier Universitaire, Amiens (1) · Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation (1)
United States (3) · France (1)
Stephen Arnon, M.D., M.P.H. (1) · Stephen S. Arnon, M.D. (1)